Private Management Group’s Amgen AMGN Stock Holding History

Private Management Group’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$527K	Buy	1,456 +2	+0.1%	+$685	0.01%	238
2026 Q1	$512K	Hold	1,454	–	–	0.01%	235
2025 Q4	$476K	Buy	1,454 +76	+6%	+$24.1K	0.01%	230
2025 Q3	$389K	Hold	1,378	–	–	0.01%	236
2025 Q2	$385K	Buy	+1,378	New	+$390K	0.01%	219

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Private Management Group's AMGN Position: Q2 2026 in Review

Private Management Group increased its Amgen (AMGN) stake by 0.14% in Q2 2026, buying an estimated $685 and bringing the position to 1,456 shares worth $527K. The position accounts for 0.01% of the portfolio, ranked #238.

Private Management Group first reported a position in AMGN in Q2 2025 and has held it in 5 quarters since. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Private Management Group held 1,456 shares of Amgen worth $527K as of Q2 2026.
Private Management Group bought 2 Amgen shares in Q2 2026, an estimated $685.
Amgen made up 0.01% of Private Management Group's portfolio in Q2 2026, its #238 holding.
Private Management Group first reported a position in Amgen in Q2 2025 and has held it in 5 quarters since.
3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Private Management Group's 13F filing for Q2 2026, filed 31 Jul 2026.